ÂÜÀòÂÒÂ×

Gary Herman, MD, joined Regeneron in 2015 and leads the Early Clinical Development & Experimental Sciences (ECDES) function. Previously, Dr. Herman, served in roles of increasing responsibility at Merck, most recently as the Vice President and Head, Early Stage Development. From 2008 to 2015, Dr. Herman was one of only three pharmaceutical industry members on the Executive Committee of the Biomarker’s Consortium, Foundation for the National Institute of Health. Prior to that, Dr. Herman completed his residency and postdoctoral training at University of California, San Francisco and was an Assistant Professor there before joining industry. He received his BS in Biochemistry and Cell Biology from the University of California, San Diego, and his MD from Harvard Medical School.